BioCentury | Oct 3, 2020
Emerging Company Profile

Emmecell: magnetic cell therapy for eye diseases

...case as an assistant professor at the University of Miami...
...the Bascom Palmer Eye Institute at the University of Miami...
...its magnetic cell delivery technology from the University of Miami...
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...from this experience, that diagnostics are a crucial component of the healthcare system.” Sylvia Daunert, University of Miami...
...is run on the company’s ID NOW hardware. Heat Biologics Inc. (NASDAQ:HBTX) partnered with the University of Miami...
...that can be used anywhere in the world by minimally trained personnel,” said Sylvia Daunert, University of Miami...
BioCentury | Sep 18, 2019
Distillery Therapeutics

TAP inhibition for multiple cancers

...21, 2019 doi:10.1038/s41467-019-11728-2 CONTACT: Eli Gilboa, University of Miami Miller School of Medicine, Miami, Fla. email: egilboa@med.miami.edu Claire Quang University of Miami...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...nephropathy Sphingomyelin phosphodiesterase acid like 3B (SMPDL3B) Inhibiting SMPDL3B could help prevent diabetic kidney disease University of Miami...
BioCentury | Jul 11, 2019
Distillery Therapeutics

SMPDL3b inhibition or C1P supplementation for diabetic kidney disease

...19, 2019 doi:10.1038/s41467-019-10584-4 CONTACT: Alessia Fornoni, University of Miami Miller School of Medicine, Miami, Fla. email: afornoni@med.miami.edu Claire Quang University of Miami...
BioCentury | Apr 22, 2019
Company News

Variant expands pipeline with InflamaCore inflammasome deal

...a 2018 paper published in Frontiers in Neurology , InflamaCore LLC (Miami, Fla.) co-founders and University of Miami...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...kinase (PNCK) Renal cancer Patient sample, cell line Inhibiting PNCK could help treat renal cancer. University of Miami...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...increase efficacy of immunotherapies for pancreatic cancer, and that gut bacteria translocate to the tumor University of Miami...
BioCentury | Mar 13, 2019
Distillery Therapeutics

Cocktails of AAV vectors encoding anti-HIV bNAbs to treat the infection

...2019 doi:10.1016/j.immuni.2019.02.005 CONTACT: Ronald C. Desrosiers, University of Miami Miller School of Medicine, Miami, Fla. e-mail: r.desrosiers@med.miami.edu Hongjiang Li University of Miami...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...University of Miami, Miami, Fla. email: andrew.schally@va.gov CONTACT: Riccarda Granata, University of Turin, Turin, Italy email: riccarda.granata@unito.it Chris Lieu University of Miami University...
Items per page:
1 - 10 of 165
BioCentury | Oct 3, 2020
Emerging Company Profile

Emmecell: magnetic cell therapy for eye diseases

...case as an assistant professor at the University of Miami...
...the Bascom Palmer Eye Institute at the University of Miami...
...its magnetic cell delivery technology from the University of Miami...
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...from this experience, that diagnostics are a crucial component of the healthcare system.” Sylvia Daunert, University of Miami...
...is run on the company’s ID NOW hardware. Heat Biologics Inc. (NASDAQ:HBTX) partnered with the University of Miami...
...that can be used anywhere in the world by minimally trained personnel,” said Sylvia Daunert, University of Miami...
BioCentury | Sep 18, 2019
Distillery Therapeutics

TAP inhibition for multiple cancers

...21, 2019 doi:10.1038/s41467-019-11728-2 CONTACT: Eli Gilboa, University of Miami Miller School of Medicine, Miami, Fla. email: egilboa@med.miami.edu Claire Quang University of Miami...
BioCentury | Aug 23, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2019

...nephropathy Sphingomyelin phosphodiesterase acid like 3B (SMPDL3B) Inhibiting SMPDL3B could help prevent diabetic kidney disease University of Miami...
BioCentury | Jul 11, 2019
Distillery Therapeutics

SMPDL3b inhibition or C1P supplementation for diabetic kidney disease

...19, 2019 doi:10.1038/s41467-019-10584-4 CONTACT: Alessia Fornoni, University of Miami Miller School of Medicine, Miami, Fla. email: afornoni@med.miami.edu Claire Quang University of Miami...
BioCentury | Apr 22, 2019
Company News

Variant expands pipeline with InflamaCore inflammasome deal

...a 2018 paper published in Frontiers in Neurology , InflamaCore LLC (Miami, Fla.) co-founders and University of Miami...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...kinase (PNCK) Renal cancer Patient sample, cell line Inhibiting PNCK could help treat renal cancer. University of Miami...
BioCentury | Mar 29, 2019
Targets & Mechanisms

AACR moves in a myeloid direction

...increase efficacy of immunotherapies for pancreatic cancer, and that gut bacteria translocate to the tumor University of Miami...
BioCentury | Mar 13, 2019
Distillery Therapeutics

Cocktails of AAV vectors encoding anti-HIV bNAbs to treat the infection

...2019 doi:10.1016/j.immuni.2019.02.005 CONTACT: Ronald C. Desrosiers, University of Miami Miller School of Medicine, Miami, Fla. e-mail: r.desrosiers@med.miami.edu Hongjiang Li University of Miami...
BioCentury | Feb 11, 2019
Distillery Therapeutics

Cancer

...University of Miami, Miami, Fla. email: andrew.schally@va.gov CONTACT: Riccarda Granata, University of Turin, Turin, Italy email: riccarda.granata@unito.it Chris Lieu University of Miami University...
Items per page:
1 - 10 of 165